Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Roudaut

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Scientific Reports|March 24, 2025
Contribution of 18 F-fluorocholine PET-CT to the preoperative localisation of parathyroid adenoma for the treatment of primary hyperparathyroidismSuzanne Garnier, Clémentine Mahéo, Gael Potard, et al.
Frontiers in Medicine|February 28, 2019
Diagnostic Value of FDG PET-CT Quantitative Parameters and Deauville-Like 5 Point-Scale in Predicting Malignancy of Focal Thyroid IncidentalomaPhilippe Thuillier, David Bourhis, Nathalie Roudaut, et al.
Annales D'Endocrinologie|July 30, 2023
Risk factors for hypothyroidism following hemithyroidectomyJulien Prévot, Gaël Potard, Philippe Thuillier, et al.
Diabetes & Metabolism|August 29, 2025
Prevalence and predictive factors of computed tomography-detected pancreatopathy in a cohort of adult patients hospitalized for newly diagnosed or uncontrolled non-auto-immune diabetesNoëmie Lemétayer, Lucille Quénéhervé, Jean-Romain Risson, et al.
Endocrine-Related Cancer|October 28, 2020
Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overviewClotilde Sparano, Yann Godbert, Marie Attard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2003
Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trialEmmanuel Oger, Martine Alhenc-Gelas, Karine Lacut, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 20, 2024
F18-Choline PET/CT or MIBI SPECT/CT in the Surgical Management of Primary Hyperparathyroidism: A Diagnostic Randomized Clinical TrialElske Quak, Audrey Lasne-Cardon, Marie Cavarec, et al.
Thyroid : Official Journal of the American Thyroid Association|October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF NetworkArnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
The New England Journal of Medicine|March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid CancerSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
The Lancet. Diabetes & Endocrinology|November 25, 2024
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trialSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Scientific Reports|March 24, 2025
Contribution of 18 F-fluorocholine PET-CT to the preoperative localisation of parathyroid adenoma for the treatment of primary hyperparathyroidismSuzanne Garnier, Clémentine Mahéo, Gael Potard, et al.
Frontiers in Medicine|February 28, 2019
Diagnostic Value of FDG PET-CT Quantitative Parameters and Deauville-Like 5 Point-Scale in Predicting Malignancy of Focal Thyroid IncidentalomaPhilippe Thuillier, David Bourhis, Nathalie Roudaut, et al.
Annales D'Endocrinologie|July 30, 2023
Risk factors for hypothyroidism following hemithyroidectomyJulien Prévot, Gaël Potard, Philippe Thuillier, et al.
Diabetes & Metabolism|August 29, 2025
Prevalence and predictive factors of computed tomography-detected pancreatopathy in a cohort of adult patients hospitalized for newly diagnosed or uncontrolled non-auto-immune diabetesNoëmie Lemétayer, Lucille Quénéhervé, Jean-Romain Risson, et al.
Endocrine-Related Cancer|October 28, 2020
Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overviewClotilde Sparano, Yann Godbert, Marie Attard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2003
Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trialEmmanuel Oger, Martine Alhenc-Gelas, Karine Lacut, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 20, 2024
F18-Choline PET/CT or MIBI SPECT/CT in the Surgical Management of Primary Hyperparathyroidism: A Diagnostic Randomized Clinical TrialElske Quak, Audrey Lasne-Cardon, Marie Cavarec, et al.
Thyroid : Official Journal of the American Thyroid Association|October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF NetworkArnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
The New England Journal of Medicine|March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid CancerSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
The Lancet. Diabetes & Endocrinology|November 25, 2024
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trialSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
Pageof 2